412 related articles for article (PubMed ID: 7826162)
1. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
Nitecki SS; Sarr MG; Colby TV; van Heerden JA
Ann Surg; 1995 Jan; 221(1):59-66. PubMed ID: 7826162
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
Conlon KC; Klimstra DS; Brennan MF
Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
4. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
Benassai G; Mastrorilli M; Quarto G; Cappiello A; Giani U; Mosella G
Chir Ital; 2000; 52(3):263-70. PubMed ID: 10932371
[TBL] [Abstract][Full Text] [Related]
5. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
6. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in the operative treatment of ductal pancreatic carcinoma.
Gebhardt C; Meyer W; Reichel M; Wünsch PH
Langenbecks Arch Surg; 2000 Jan; 385(1):14-20. PubMed ID: 10664114
[TBL] [Abstract][Full Text] [Related]
8. Survival after resection for ductal adenocarcinoma of the pancreas.
Sperti C; Pasquali C; Piccoli A; Pedrazzoli S
Br J Surg; 1996 May; 83(5):625-31. PubMed ID: 8689203
[TBL] [Abstract][Full Text] [Related]
9. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
[TBL] [Abstract][Full Text] [Related]
10. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
11. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
[TBL] [Abstract][Full Text] [Related]
13. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
Lüttges J; Vogel I; Menke M; Henne-Bruns D; Kremer B; Klöppel G
Virchows Arch; 1998 Sep; 433(3):237-42. PubMed ID: 9769127
[TBL] [Abstract][Full Text] [Related]
14. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
17. Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan.
Mukaiya M; Hirata K; Satoh T; Kimura M; Yamashiro K; Ura H; Oikawa I; Denno R
World J Surg; 1998 Mar; 22(3):248-52; discussion 252-3. PubMed ID: 9494416
[TBL] [Abstract][Full Text] [Related]
18. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
19. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.
Fortner JG; Klimstra DS; Senie RT; Maclean BJ
Ann Surg; 1996 Feb; 223(2):147-53. PubMed ID: 8597508
[TBL] [Abstract][Full Text] [Related]
20. Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas.
Garcea G; Dennison AR; Ong SL; Pattenden CJ; Neal CP; Sutton CD; Mann CD; Berry DP
Eur J Surg Oncol; 2007 Sep; 33(7):892-7. PubMed ID: 17398060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
